These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18230675)

  • 1. Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test.
    Walker DL; Davis M
    Learn Mem; 2008 Feb; 15(2):67-74. PubMed ID: 18230675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDA currents and receptor protein are downregulated in the amygdala during maintenance of fear memory.
    Zinebi F; Xie J; Liu J; Russell RT; Gallagher JP; McKernan MG; Shinnick-Gallagher P
    J Neurosci; 2003 Nov; 23(32):10283-91. PubMed ID: 14614087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditioning-strength dependent involvement of NMDA NR2B subtype receptor in the basolateral nucleus of amygdala in acquisition of auditory fear memory.
    Zhang XH; Liu F; Chen Q; Zhang CL; Zhuo M; Xiong ZQ; Li BM
    Neuropharmacology; 2008 Aug; 55(2):238-46. PubMed ID: 18573264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.
    Walker DL; Ressler KJ; Lu KT; Davis M
    J Neurosci; 2002 Mar; 22(6):2343-51. PubMed ID: 11896173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injections of the NMDA receptor antagonist aminophosphonopentanoic acid into the lateral nucleus of the amygdala block the expression of fear-potentiated startle and freezing.
    Fendt M
    J Neurosci; 2001 Jun; 21(11):4111-5. PubMed ID: 11356899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR2B subunit of the NMDA receptor in the basolateral amygdala is necessary for the acquisition of conditioned defeat in Syrian hamsters.
    Day DE; Cooper MA; Markham CM; Huhman KL
    Behav Brain Res; 2011 Feb; 217(1):55-9. PubMed ID: 20933543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning.
    Rodrigues SM; Schafe GE; LeDoux JE
    J Neurosci; 2001 Sep; 21(17):6889-96. PubMed ID: 11517276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear.
    Dalton GL; Wu DC; Wang YT; Floresco SB; Phillips AG
    Neuropharmacology; 2012 Feb; 62(2):797-806. PubMed ID: 21925518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended fear conditioning reveals a role for both N-methyl-D-aspartic acid and non-N-methyl-D-aspartic acid receptors in the amygdala in the acquisition of conditioned fear.
    Pistell PJ; Falls WA
    Neuroscience; 2008 Sep; 155(4):1011-20. PubMed ID: 18675886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression.
    Walker DL; Paschall GY; Davis M
    Learn Mem; 2005; 12(2):120-9. PubMed ID: 15774945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear.
    Walker DL; Davis M
    J Neurosci; 1997 Dec; 17(23):9375-83. PubMed ID: 9364083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infusion of the non-NMDA receptor antagonist CNQX into the amygdala blocks the expression of fear-potentiated startle.
    Kim M; Campeau S; Falls WA; Davis M
    Behav Neural Biol; 1993 Jan; 59(1):5-8. PubMed ID: 8095136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Methyl-D-aspartate receptor antagonism blocks contextual fear conditioning and differentially regulates early growth response-1 messenger RNA expression in the amygdala: implications for a functional amygdaloid circuit of fear.
    Malkani S; Rosen JB
    Neuroscience; 2001; 102(4):853-61. PubMed ID: 11182248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of NMDA receptors within the amygdala in short- versus long-term memory for fear conditioning as assessed with fear-potentiated startle.
    Walker DL; Davis M
    Behav Neurosci; 2000 Dec; 114(6):1019-33. PubMed ID: 11142635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of bed nucleus of the stria terminalis and amygdala AMPA receptors in the development and expression of context conditioning and sensitization of startle by prior shock.
    Davis M; Walker DL
    Brain Struct Funct; 2014 Nov; 219(6):1969-82. PubMed ID: 23934654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition.
    Spooren W; Mombereau C; Maco M; Gill R; Kemp JA; Ozmen L; Nakanishi S; Higgins GA
    Psychopharmacology (Berl); 2004 Aug; 175(1):99-105. PubMed ID: 14985927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
    Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual pathways involved in fear conditioning measured with fear-potentiated startle: behavioral and anatomic studies.
    Shi C; Davis M
    J Neurosci; 2001 Dec; 21(24):9844-55. PubMed ID: 11739592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus.
    Campeau S; Miserendino MJ; Davis M
    Behav Neurosci; 1992 Jun; 106(3):569-574. PubMed ID: 1352104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.